AcuraBio

AcuraBio is one of the most experienced biopharmaceutical CDMOs in Australia, providing trusted, customer-centric services to domestic and international clients over the past 20 years. AcuraBio offers crucial quality, cost, and intellectual property guarantees to biopharmaceutical companies worldwide. World-class researchers, established facilities, a streamlined regulatory framework, generous tax incentives, and government funding make Australia a prime location for biotechnology research. AcuraBio holds the following operational licenses: TGA (Australia’s FDA equivalent) license for manufacturing human therapeutic APIs from biological and synthetic sources, APVMA (TGA equivalent for veterinary use) license for manufacturing sterile immune biological products, OGTR license for producing products from genetically modified organisms, and DAF facility license for importing and using biological materials.